Journal of Medicinal Chemistry
Article
(3) Ruat, M.; Roudaut, H.; Ferent, J.; Traiffort, E. Hedgehog
trafficking, cilia and brain functions. Differentiation 2012, 83, S97−
S104.
(4) Philipp, M.; Caron, M. G. Hedgehog signaling: is Smo a G
protein-coupled receptor? Curr. Biol. 2009, 19, R125−R127.
(5) Barakat, M. T.; Humke, E. W.; Scott, M. P. Learning from Jekyll
to control Hyde: Hedgehog signaling in development and cancer.
Trends Mol. Med. 2010, 16, 337−348.
(6) Tian, H.; Callahan, C. A.; DuPree, K. J.; Darbonne, W. C.; Ahn,
C. P.; Scales, S. J.; de Sauvage, F. J. Hedgehog signaling is restricted to
the stromal compartment during pancreatic carcinogenesis. Proc. Natl.
Acad. Sci. U.S.A. 2009, 106, 4254−4259.
(7) Nieuwenhuis, E.; Hui, C. C. Hedgehog signaling and congenital
malformations. Clin. Genet. 2005, 67, 193−208.
Peukert, S.; Pan, S.; Wu, X.; Maira, S. M.; Garcia-Echeverria, C.;
Briggs, K. J.; Watkins, D. N.; Yao, Y. M.; Lengauer, C.; Warmuth, M.;
Sellers, W. R.; Dorsch, M. Interfering with resistance to Smoothened
antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci.
Transl. Med. 2010, 2, 51ra70.
(20) Manetti, F.; Faure, H.; Roudaut, H.; Gorojankina, T.; Traiffort,
E.; Schoenfelder, A.; Mann, A.; Solinas, A.; Taddei, M.; Ruat, M.
Virtual screening-based discovery and mechanistic characterization of
the acylthiourea MRT-10 family as Smoothened antagonists. Mol.
Pharmacol. 2010, 78, 658−665.
(21) Hallur, G.; Jimeno, A.; Dalrymple, S.; Zhu, T.; Jung, M. K.;
Hidalgo, M.; Isaacs, J. T.; Sukumar, S.; Hamel, E.; Khan, S. R.
Benzoylphenylurea sulfur analogues with potent antitumor activity.
J. Med. Chem. 2006, 49, 2357−2360.
(8) Traiffort, E.; Dubourg, C.; Faure, H.; Rognan, D.; Odent, S.;
Durou, M. R.; David, V.; Ruat, M. Functional characterization of Sonic
Hedgehog mutations associated with holoprosencephaly. J. Biol. Chem.
2004, 279, 42889−42897.
(22) Okada, H.; Koyanagi, T.; Yamada, N.; Haga, T. Synthesis and
antitumor activities of novel benzoylphenylurea derivatives. Chem.
Pharm. Bull. (Tokyo) 1991, 39, 2308−2315.
(23) Klabunde, T.; Wendt, K. U.; Kadereit, D.; Brachvogel, V.;
Burger, H. J.; Herling, A. W.; Oikonomakos, N. G.; Kosmopoulou, M.
N.; Schmoll, D.; Sarubbi, E.; von Roedern, E.; Schonafinger, K.;
Defossa, E. Acyl ureas as human liver glycogen phosphorylase
inhibitors for the treatment of type 2 diabetes. J. Med. Chem. 2005,
48, 6178−6193.
(24) Furuta, T.; Sakai, T.; Senga, T.; Osawa, T.; Kubo, K.; Shimizu,
T.; Suzuki, R.; Yoshino, T.; Endo, M.; Miwa, A. Identification of
potent and selective inhibitors of PDGF receptor autophosphorylation.
J. Med. Chem. 2006, 49, 2186−2192.
(25) Haynes, N. E.; Corbett, W. L.; Bizzarro, F. T.; Guertin, K. R.;
Hilliard, D. W.; Holland, G. W.; Kester, R. F.; Mahaney, P. E.; Qi, L.;
Spence, C. L.; Tengi, J.; Dvorozniak, M. T.; Railkar, A.; Matschinsky,
F. M.; Grippo, J. F.; Grimsby, J.; Sarabu, R. Discovery, structure−
activity relationships, pharmacokinetics, and efficacy of glucokinase
activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-
2-yl-propionamide (RO0281675). J. Med. Chem. 2010, 53, 3618−
3625.
(9) Teglund, S.; Toftgard, R. Hedgehog: beyond medulloblastoma
and basal cell carcinoma. Biochim. Biophys. Acta 2010, 1805, 181−208.
(10) Berman, D. M.; Karhadkar, S. S.; Hallahan, A. R.; Pritchard, J. I.;
Eberhart, C. G.; Watkins, D. N.; Chen, J. K.; Cooper, M. K.; Taipale,
J.; Olson, J. M.; Beachy, P. A. Medulloblastoma growth inhibition by
Hedgehog pathway blockade. Science 2002, 297, 1559−1561.
(11) Miller-Moslin, K.; Peukert, S.; Jain, R. K.; McEwan, M. A.; Karki,
R.; Llamas, L.; Yusuff, N.; He, F.; Li, Y.; Sun, Y.; Dai, M.; Perez, L.;
Michael, W.; Sheng, T.; Lei, H.; Zhang, R.; Williams, J.; Bourret, A.;
Ramamurthy, A.; Yuan, J.; Guo, R.; Matsumoto, M.; Vattay, A.;
Maniara, W.; Amaral, A.; Dorsch, M.; Kelleher, J. F. III. 1-Amino-4-
benzylphthalazines as orally bioavailable Smoothened antagonists with
antitumor activity. J. Med. Chem. 2009, 52, 3954−3968.
(12) Pan, S.; Wu, X.; Jiang, J.; Gao, W.; Wan, Y.; Cheng, D.; Han, D.;
Liu, J.; Englund, N. P.; Wang, Y.; Peukert, S.; Miller-Moslin, K.; Yuan,
J.; Guo, R.; Matsumoto, M.; Vattay, A.; Jiang, Y.; Tsao, J.; Sun, F.;
Pferdekamper, A. C.; Dodd, S.; Tuntland, T.; Maniara, W.; Kelleher, J.
F.; Yao, Y.-m.; Warmuth, M.; Williams, J.; Dorsch, M. Discovery of
NVP-LDE225, a Potent and Selective Smoothened Antagonist.
ACS Med. Chem. Lett. 2010, 1, 130−134.
(13) Peukert, S.; Miller-Moslin, K. Small-molecule inhibitors of the
hHedgehog signaling pathway as cancer therapeutics. ChemMedChem
2010, 5, 500−512.
(26) Keller, M.; Pop, N.; Hutzler, C.; Beck-Sickinger, A. G.;
Bernhardt, G.; Buschauer, A. Guanidine−acylguanidine bioisosteric
approach in the design of radioligands: synthesis of a tritium-labeled
N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent
and selective neuropeptide Y Y1 receptor antagonist. J. Med. Chem.
2008, 51, 8168−8172.
(14) ClinicalTrials.gov; National Institutes of Health: Bethesda, MD;
(15) Rudin, C. M.; Hann, C. L.; Laterra, J.; Yauch, R. L.; Callahan, C.
A.; Fu, L.; Holcomb, T.; Stinson, J.; Gould, S. E.; Coleman, B.;
LoRusso, P. M.; Von Hoff, D. D.; de Sauvage, F. J.; Low, J. A.
Treatment of medulloblastoma with Hedgehog pathway inhibitor
GDC-0449. N. Engl. J. Med. 2009, 361, 1173−1178.
(16) Von Hoff, D. D.; Lorusso, P. M.; Rudin, C. M.; Reddy, J. C.;
Yauch, R. L.; Tibes, R.; Weiss, G. J.; Borad, M. J.; Hann, C. L.;
Brahmer, J. R.; Mackey, H. M.; Lum, B. L.; Darbonne, W. C.; Marsters,
J. C.; de Sauvage, F. J.; Low, J. A. Inhibition of the Hedgehog Pathway
in Advanced Basal-Cell Carcinoma. N. Engl. J. Med. 2009, 361, 1164−
1172.
(17) Yauch, R. L.; Dijkgraaf, G. J.; Alicke, B.; Januario, T.; Ahn, C. P.;
Holcomb, T.; Pujara, K.; Stinson, J.; Callahan, C. A.; Tang, T.; Bazan,
J. F.; Kan, Z.; Seshagiri, S.; Hann, C. L.; Gould, S. E.; Low, J. A.; Rudin,
C. M.; de Sauvage, F. J. Smoothened Mutation Confers Resistance to a
Hedgehog Pathway Inhibitor in Medulloblastoma. Science 2009, 326,
572−574.
(18) Dijkgraaf, G. J.; Alicke, B.; Weinmann, L.; Januario, T.; West, K.;
Modrusan, Z.; Burdick, D.; Goldsmith, R.; Robarge, K.; Sutherlin, D.;
Scales, S. J.; Gould, S. E.; Yauch, R. L.; de Sauvage, F. J. Small molecule
inhibition of GDC-0449 refractory Smoothened mutants and
downstream mechanisms of drug resistance. Cancer Res. 2010, 71,
435−444.
(19) Buonamici, S.; Williams, J.; Morrissey, M.; Wang, A.; Guo, R.;
Vattay, A.; Hsiao, K.; Yuan, J.; Green, J.; Ospina, B.; Yu, Q.; Ostrom,
L.; Fordjour, P.; Anderson, D. L.; Monahan, J. E.; Kelleher, J. F.;
(27) Kleinmaier, R.; Keller, M.; Igel, P.; Buschauer, A.; Gschwind,
R. M. Conformations, conformational preferences, and conformational
exchange of N′-substituted N-acylguanidines: intermolecular inter-
actions hold the key. J. Am. Chem. Soc. 2010, 132, 11223−11233.
(28) Narasimhamurthy, N.; Samuelson, A. G. Thiocarbonyl to
carbonyl group transformation using CuCl and NaOH. Tetrahedron
Lett. 1986, 27, 3911−3912.
(29) Shinada, T.; Umezawa, T.; Ando, T.; Kozuma, H.; Ohfune, Y.
A new entry for the synthesis of N-acyl-N′-substituted guanidines.
Tetrahedron Lett. 2006, 47, 1945−1947.
(30) Daga, M. C.; Taddei, M.; Varchi, G. Rapid microwave-assisted
deprotection of N-Cbz and N-Bn derivatives. Tetrahedron Lett. 2001,
5191−5194.
(31) Bellamy, F. D.; Ou, K. Selective reduction of aromatic nitro
compounds with stannous chloride in nonacidic and nonaqueous
medium. Tetrahedron Lett. 1984, 25, 839−842.
(32) Rasmussen, C. R.; Villani, J. F. J.; Weaner, , L. E.; Reynolds, B.
E.; Hood, A. R.; Hecker, L. R.; Nortey, S. O.; Hanslin, A.; Costanzo,
M. J.; Powell, E. T.; Molinari, A. J. Improved Procedures for the
Preparation of Cycloalkyl-, Arylalkyl-, and Arylthioureas. Synthesis
1988, 456−459.
(33) Yang, G.; Chen, Z.; Zhang, H. Clean synthesis of an array of
N-benzoyl-N′-aryl ureas using polymer-supported reagents. Green
Chem. 2003, 441−442.
(34) Taipale, J.; Chen, J. K.; Cooper, M. K.; Wang, B.; Mann, R. K.;
Milenkovic, L.; Scott, M. P.; Beachy, P. A. Effects of oncogenic
mutations in Smoothened and Patched can be reversed by
cyclopamine. Nature 2000, 406, 1005−1009.
1570
dx.doi.org/10.1021/jm2013369 | J. Med. Chem. 2012, 55, 1559−1571